Circulating tumor cells (CTCs) detected by CK19 mRNA positive can be found in peripheral blood samples of breast cancer patients, and there are correlations between circulating CK19 mRNA positive and poor prognosis7–11. This evidence concerns the gene KRT19 and neoplasm.